1. Home
  2. VREX vs ENTA Comparison

VREX vs ENTA Comparison

Compare VREX & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$12.17

Market Cap

483.7M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.43

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
ENTA
Founded
2016
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.7M
407.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VREX
ENTA
Price
$12.17
$14.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$16.67
$20.40
AVG Volume (30 Days)
356.4K
290.8K
Earning Date
02-05-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$844,600,000.00
$65,324,000.00
Revenue This Year
$4.79
$0.99
Revenue Next Year
$4.15
$0.19
P/E Ratio
N/A
N/A
Revenue Growth
4.14
N/A
52 Week Low
$6.76
$4.09
52 Week High
$15.46
$15.34

Technical Indicators

Market Signals
Indicator
VREX
ENTA
Relative Strength Index (RSI) 61.87 61.51
Support Level $11.71 $14.07
Resistance Level $12.00 $15.28
Average True Range (ATR) 0.33 0.75
MACD 0.08 -0.08
Stochastic Oscillator 91.26 52.94

Price Performance

Historical Comparison
VREX
ENTA

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: